English
Segment disclosures
Company overviewCAREDX, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Patient And Digital Solutions · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cdna:PatientAndDigitalSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 19230000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 35186000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 15956000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 56933000 | USD | 20260225 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 15409000 | USD | 20251104 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 40176000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 12813000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 24767000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 11954000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 43621000 | USD | 20260225 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 11864000 | USD | 20251104 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 32228000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 10746000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 20364000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9618000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 37122000 | USD | 20260225 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 28794000 | USD | 20250228 | Open filing evidence |
Product · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 12791000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 23137000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 10346000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 48377000 | USD | 20260225 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 12478000 | USD | 20251104 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 35121000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 11833000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 22643000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10810000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 40783000 | USD | 20260225 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 10212000 | USD | 20251104 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 29416000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 10610000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 19204000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 8594000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 33517000 | USD | 20260225 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 29251000 | USD | 20250228 | Open filing evidence |
Service · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 99927000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 191325000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 91398000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 274495000 | USD | 20260225 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 72168000 | USD | 20251104 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 196122000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 62033000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 123954000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 61921000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 249381000 | USD | 20260225 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 60807000 | USD | 20251104 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 185562000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 70918000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 124755000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 53837000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 209685000 | USD | 20260225 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 263748000 | USD | 20250228 | Open filing evidence |
Rest Of The World · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180809 | Open filing evidence |
Rest Of The World · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 276000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 607000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 405000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 897000 | USD | 20180809 | Open filing evidence |
AU · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180809 | Open filing evidence |
AU · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 31000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 105000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 125000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 241000 | USD | 20180809 | Open filing evidence |
Europe · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 24000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 41000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 23000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 38000 | USD | 20180809 | Open filing evidence |
Europe · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 1856000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 3829000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1863000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 3922000 | USD | 20180809 | Open filing evidence |
North America · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 14147000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 24876000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 8647000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 16549000 | USD | 20180809 | Open filing evidence |
North America · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 1489000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2418000 | USD | 20180809 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 983000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 1983000 | USD | 20180809 | Open filing evidence |
Allenex
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:AllenexMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-04-01 – 2016-06-30 | 3475000 | USD | 20160822 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 3475000 | USD | 20160822 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 0 | USD | 20160822 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 0 | USD | 20160822 | Open filing evidence |
Care Dx
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:CareDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-07-01 – 2017-09-30 | 8319000 | USD | 20171109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 24905000 | USD | 20171109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 8670000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 16587000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 7917000 | USD | 20170609 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 29917000 | USD | 20170421 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 8721000 | USD | 20171109 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 22543000 | USD | 20171109 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 7260000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 13822000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 6562000 | USD | 20170609 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 28144000 | USD | 20170421 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 7151000 | USD | 20161115 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 21496000 | USD | 20161115 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 7129000 | USD | 20160822 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 14344000 | USD | 20160822 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 27306000 | USD | 20170421 | Open filing evidence |
Olerup
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:OlerupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-07-01 – 2017-09-30 | 3872000 | USD | 20171109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 10916000 | USD | 20171109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 3376000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 7043000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 3667000 | USD | 20170609 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 10714000 | USD | 20170421 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 3754000 | USD | 20171109 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 7228000 | USD | 20171109 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 3475000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 3475000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 0 | USD | 20170609 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 0 | USD | 20170421 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 0 | USD | 20161115 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 0 | USD | 20161115 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 0 | USD | 20170421 | Open filing evidence |
Post Transplant
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 14171000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 24917000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 10746000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 33690000 | USD | 20180322 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 8670000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 16587000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 7917000 | USD | 20180510 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 29916000 | USD | 20180322 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 28144000 | USD | 20180322 | Open filing evidence |
Pre Transplant
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 3652000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 6959000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 3307000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 14634000 | USD | 20180322 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 3376000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 7043000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 3667000 | USD | 20180510 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 10715000 | USD | 20180322 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 0 | USD | 20180322 | Open filing evidence |
Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 139362000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 389010000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 131948000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 249648000 | USD | 20260730 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 117700000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 379805000 | USD | 20260225 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 100055000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 271419000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 86679000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 171364000 | USD | 20260730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 84685000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 333785000 | USD | 20260225 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 82883000 | USD | 20251104 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 247206000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 92274000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 164323000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 72049000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 280324000 | USD | 20260225 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 321793000 | USD | 20250228 | Open filing evidence |
Reportable Segment · Patient And Digital Solutions
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=cdna:PatientAndDigitalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 20171000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 55357000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 15409000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 40176000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
Reportable Segment · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 23137000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 12478000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 35121000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
Reportable Segment · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 119191000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 310516000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 72168000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 196122000 | USD | 2026-10-29 · 20:04:25.000Z | Open filing evidence |
Rest Of The World · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 0 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 0 | USD | 20180510 | Open filing evidence |
Rest Of The World · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 331000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 492000 | USD | 20180510 | Open filing evidence |
AU · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 0 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 0 | USD | 20180510 | Open filing evidence |
AU · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 74000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 116000 | USD | 20180510 | Open filing evidence |
Europe · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 17000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 15000 | USD | 20180510 | Open filing evidence |
Europe · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 1973000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 2059000 | USD | 20180510 | Open filing evidence |
North America · Post Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 10729000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 7902000 | USD | 20180510 | Open filing evidence |
North America · Pre Transplant
Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 929000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 1000000 | USD | 20180510 | Open filing evidence |